India’s Liberalised FDI Policy Boosts Investor Confidence And Sectoral Growth
India's liberalised FDI policy is providing global investors with a stable and predictable environment, offering sector-neutral opportunities.
Indian Pharma Sector Sees Strong Growth; Faces Emerging Challenges
McKinsey & Company reports India's pharmaceutical sector grew at an 8% CAGR, with exports rising by 9% in 2024.
